tallózása szerző szerint "Hauser, Péter"

A találatok rendezése: Rendezés: Találatok:

  • Advanced Pediatric Inoperable Thymus Carcinoma (Type C Thymoma) 
    Kertész, Gabriella; Hauser, Péter; Varga P; Dabasi, Gabriella; Schuler, Dezső; Garami, Miklós (2007)
    Although there has been considerable advancement in treatment techniques but still there are some illnesses that continue to exhibit a rather poor curability, such as thymoma. This report highlights the benefit of ...
  • A Ewing-sarcomás betegek tünetmentes túlélési esélyeinek értékelése a Gyermekonkológiai Szekció eredményei alapján 
    Babosa M; Garami, Miklós; Hauser, Péter; Schuler, Dezső; Szendrői, Miklós (2000)
    Correlation between different prognostic factors and the overall survival of Ewing's sarcoma patients has been investigted. In this study data have been selected from the databank of Hungarian Pediatric Oncologist ...
  • Age and DNA-methylation subgroup as potential independent risk factors for treatment stratification in children with Atypical Teratoid/Rhabdoid Tumors (ATRT) 
    Frühwald, Michael C; Hasselblatt, Martin; Nemes, Karolina; Bens, Susanne; Steinbügl, Mona; Johann, Pascal D; Kerl, Kornelius; Hauser, Péter; Quiroga, Eduardo; Solano-Paez, Palma; Biassoni, Veronica; Gil-da-Costa, Maria Joao; Perek-Polnik, Martha; van de Wetering, Marianne; Sumerauer, David; Pears, Jane; Stabell, Niklas; Holm, Stefan; Hengartner, Heinz; Gerber, Nicolas U; Grotzer, Michael; Boos, Joachim; Ebinger, Martin; Tippelt, Stefan; Paulus, Werner; Furtwängler, Rhoikos; Hernáiz-Driever, Pablo; Reinhard, Harald; Rutkowski, Stefan; Schlegel, Paul-Gerhardt; Schmid, Irene; Kortmann, Rolf-Dieter; Timmermann, Beate; Warmuth-Metz, Monika; Kordes, Uwe; Gerss, Joachim; Nysom, Karsten; Schneppenheim, Reinhard; Siebert, Reiner; Kool, Marcel; Graf, Norbert (2020)
    Controversy exists as to what may be defined as standard of care (including markers for stratification) for patients with Atypical Teratoid Rhabdoid Tumors (ATRT). The European Rhabdoid Registry, EU-RHAB, recruits uniformly ...
  • A gyermekkori medulloblastoma késői neurokognitív mellékhatásai 
    Szentes, Annamária; Erős Nikoletta; Kekecs Zoltán; Jakab, Zsuzsanna; Török, Szabolcs; Schuler, Dezső; Hauser, Péter; Garami, Miklós (2018)
  • A gyermekkori medulloblastoma késői neurokognitív mellékhatásai 
    Szentes, Annamária; Erős Nikoletta; Kekecs Zoltán; Jakab, Zsuzsanna; Török, Szabolcs János; Schuler, Dezső; Hauser, Péter; Garami, Miklós (2018)
  • A korai diagnózis felállításának nehézségei a gyermekonkológiában – fókuszban a Ewing-szarkóma és a neuroblasztóma 
    Enzsöl Veronika; Jakab, Zsuzsanna; Hauser, Péter; Garami, Miklós (2012)
  • A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain 
    Knoll, József; Baghy, Kornélia; Eckhardt S; Ferdinandy, Péter; Garami, Miklós; Hársing, László Gábor; Hauser, Péter; Mervai, Zsolt; Pócza, Tímea; Schaff, Zsuzsa; Schuler, Dezső; Miklya, Ildikó (2017)
    AIMS: First proof to show that (-)-deprenyl/selegiline (DEP), the first selective inhibitor of MAO-B, later identified as the first beta-phenylethylamine (PEA)-derived synthetic catecholaminergic activity enhancer (CAE) ...
  • A Semmelweis Egyetemen kezelt Ewing-szarkómás gyermekek kezelési eredményeinek vizsgálata 
    Geszl, Zsófia; Kiss, János; Szendrői, Miklós; Vízkeleti, Júlia; Arató, Gabriella; Sápi, Zoltán; Kriván, Gergely; Mohás, Anna; Rényi, Imre; Garami, Miklós; Hauser, Péter (2018)
  • Atypical teratoid/rhabdoid tumor arising in a malignant glioma 
    Bozzai, Barbara; Hasselblatt M; Turányi, Eszter; Fruhwald MC; Siebert R; Bens S; Schneppenheim R; Kool M; Stelczer G; Hortobagyi T; Hauser, Péter (2017)
    Atypical teratoid/rhabdoid tumor (AT/RT), a highly malignant brain tumor in young children, usually arises de novo and has only rarely been described as a secondary malignancy. Here, we present a case of a child with ...
  • Az orvosi kommunikáció sajátosságai a gyermekonkológia területén, különös tekintettel a palliatív ellátásra 
    Földesi, Eszter; Hauser, Péter; Hegedűs, Katalin (2020)
  • Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary 
    Müller, Judit; Szűcs-Farkas, Dóra; Szegedi, István; Csóka, Monika; Garami, Miklós; Tiszlavicz, Lilla Györgyi; Hauser, Péter; Kriván, Gergely; Csanádi, Krisztina; Ottóffy, Gábor; Nagy, Béla; Kiss, Csongor; Kovács, Gábor (2022)
    We report on children with cancer in Hungary suffering from COVID-19, surveying a 13-months-long period of time. We performed a retrospective clinical trial studying the medical documentation of children treated in seven ...
  • Cribriform neuroepithelial tumor: Molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome. 
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Hess K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser, Péter; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DT; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Fruhwald MC; Kool M; Hasselblatt M (2017)
    Rhabdoid phenotype and loss of SMARCB1 expression in a brain tumor are characteristic features of atypical teratoid/rhabdoid tumors (ATRT). Rare non-rhabdoid brain tumors showing cribriform growth pattern and SMARCB1 loss ...
  • Cytogenetic Prognostication Within Medulloblastoma Subgroups 
    Shih, DJ; Northcott, PA; Remke, M; Korshunov, A; Ramaswamy, V; Kool, M; Luu, B; Yao, Y; Wang, X; Dubuc, AM; Garzia, L; Peacock, J; Mack, SC; Wu, X; Rolider, A; Morrissy, AS; Cavalli, FM; Jones, DT; Zitterbart, K; Faria, CC; Schuller, U; Kren, L; Kumabe, T; Tominaga, T; Shin, Ra Y; Garami, Miklós; Hauser, Péter; Chan, JA; Robinson, S; Bognár, László; Klekner, Álmos; Saad, AG; Liau, LM; Albrecht, S; Fontebasso, A; Cinalli, G; De Antonellis, P; Zollo, M; Cooper, MK; Thompson, RC; Bailey, S; Lindsey, JC; Di Rocco, C; Massimi, L; Michiels, EM; Scherer, SW; Phillips, JJ; Gupta, N; Fan, X; Muraszko, KM; Vibhakar, R; Eberhart, CG; Fouladi, M; Lach, B; Jung, S; Wechsler-Reya, RJ; Fevre-Montange, M; Jouvet, A; Jabado, N; Pollack, IF; Weiss, WA; Lee, JY; Cho, BK; Kim, SK; Wang, KC; Leonard, JR; Rubin, JB; de Torres, C; Lavarino, C; Mora, J; Cho, YJD; Tabori, U; Olson, JM; Gajjar, A; Packer, RJ; Rutkowski, S; Pomeroy, SL; French, PJ; Kloosterhof, NK; Kros, JM; Van, Meir EG; Clifford, SC; Bourdeaut, F; Delattre, O; Doz, FF; Hawkins, CE; Malkin, D; Grajkowska, WA; Perek-Polnik, M; Bouffet, E; Rutka, JT; Pfister, SM; Taylor, M (2014)
    PURPOSE: Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and Group 4. Current medulloblastoma protocols stratify patients based on clinical features: patient age, metastatic stage, extent ...
  • DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. 
    Schwalbe EC; Williamson D; Lindsey JC; Hamilton D; Ryan SL; Megahed H; Garami, Miklós; Hauser, Péter; Dembowska-Baginska B; Perek D; Northcott PA; Taylor MD; Taylor RE; Ellison DW; Bailey S; Clifford SC (2013)
    Molecular subclassification is rapidly informing the clinical management of medulloblastoma. However, the disease remains associated with poor outcomes and therapy-associated late effects, and the majority of patients are ...
  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma 
    Schwartzentruber, J; Korshunov, A; Liu, XY; Jones, DT; Pfaff, E; Jacob, K; Sturm, D; Fontebasso, AM; Quang, DA; Tonjes, M; Hovestadt, V; Albrecht, S; Kool, M; Nantel, A; Konermann, C; Lindroth, A; Jager, N; Rausch, T; Ryzhova, M; Korbel, JO; Hielscher, T; Hauser, Péter; Garami, Miklós; Klekner, Álmos; Bognár, László; Ebinger, M; Schuhmann, MU; Scheurlen, W; Pekrun, A;; Fruhwald, MC; Roggendorf, W; Kramm, C; Durken, M; Atkinson, J; Lepage, P; Montpetit, A; Zakrzewska, M; Zakrzewski, K; Liberski, PP; Dong, Z; Siegel, P; Kulozik, AE; Zapatka, M; Guha, A; Malkin, D; Felsberg, J; Reifenberger, G; von Deimling, A; Ichimura, K; Collins, VP; Witt, H; Milde, T; Witt, O; Zhang, C; Castelo-Branco, P; Lichter, P; Faury, D; Tabori, U; Plass, C; Majewski, J; Pfister, SM; Jabado, N (2012)
    Glioblastoma multiforme (GBM) is a lethal brain tumour in adults and children. However, DNA copy number and gene expression signatures indicate differences between adult and paediatric cases. To explore the genetic events ...
  • Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours 
    Jacob K; Albrecht S; Sollier C; Faury D; Sader E; Montpetit A; Serre D; Hauser, Péter; Garami, Miklós; Bognár, László; Hanzély Z; Montes JL; Atkinson J; Farmer JP; Bouffet E; Hawkins C; Tabori U; Jabado N (2009)
    BACKGROUND: Juvenile pilocytic astrocytomas (JPA), a subgroup of low-grade astrocytomas (LGA), are common, heterogeneous and poorly understood subset of brain tumours in children. Chromosomal 7q34 duplication leading to ...
  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma 
    Northcott PA; Lee C; Zichner T; Stutz AM; Erkek S; Kawauchi D; Shih DJ; Hovestadt V; Zapatka M; Sturm D; Jones DT; Kool M; Remke M; Cavalli FM; Zuyderduyn S; Bader GD; VandenBerg S; Esparza LA; Ryzhova M; Wang W; Wittmann A; Stark S; Sieber L; Seker-Cin H; Linke L; Kratochwil F; Jager N; Buchhalter I; Imbusch CD; Zipprich G; Raeder B; Schmidt S; Diessl N; Wolf S; Wiemann S; Brors B; Lawerenz C; Eils J; Warnatz HJ; Risch T; Yaspo ML; Weber UD; Bartholomae CC; von Kalle C; Turányi, Eszter; Hauser, Péter; Sanden E; Darabi A; Siesjo P; Sterba J; Zitterbart K; Sumerauer D; van Sluis P; Versteeg R; Volckmann R; Koster J; Schuhmann MU; Ebinger M; Grimes HL; Robinson GW; Gajjar A; Mynarek M; von Hoff K; Rutkowski S; Pietsch T; Scheurlen W; Felsberg J; Reifenberger G; Kulozik AE; von Deimling A; Witt O; Eils R; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Korbel JO; Wechsler-Reya RJ; Pfister SM (2014)
    Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to the developing child. Genomics has ...
  • Erratum: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (Nature (2012) 482 (226-231)) 
    Schwartzentruber J; Korshunov A; Liu X-Y; Jones DTW; Pfaff E; Jacob K; Sturm D; Fontebasso AM; Quang D-AK; Tönjes M; Hovestadt V; Albrecht S; Kool M; Nantel A; Konermann C; Lindroth A; Jäger N; Rausch T; Ryzhova M; Korbel JO; Hielscher T; Hauser, Péter; Garami, Miklós; Klekner, Álmos; Bognár, László; Ebinger M; Schuhmann MU; Scheurlen W; Pekrun A; Frühwald MC; Roggendorf W; Kramm C; Dürken M; Atkinson J; Lepage P; Montpetit A; Zakrzewska M; Zakrzewski K; Liberski PP; Dong Z; Siegel P; Kulozik AE; Zapatka M; Guha A; Malkin D; Felsberg J; Reifenberger G; Von Deimling A; Ichimura K; Collins VP; Witt H; Milde T; Witt O; Zhang C; Castelo-Branco P; Lichter P; Faury D; Tabori U; Plass C; Majewski J; Pfister SM; Jabado N (2012)
  • Evaluation of the good tumor response of embryonal tumor with abundant neuropil and true rosettes (ETANTR). 
    Mózes, Petra; Hauser, Péter; Hortobágyi, Tibor; Benyo G; Peták, István; Garami, Miklós; Cserháti, Adrienn; Bartyik K; Bognár, László; Nagy, Zoltán; Turányi, Eszter; Hideghéty, Katalin (2016)
    The embryonal tumor with abundant neuropil and true rosettes is a rare and highly malignant variant of embryonal brain tumors. It usually affects infants and young children under the age of 4 years and exhibits a very ...
  • Expression and Prognostic Examination of Heat Shock Proteins (HSP 27, HSP 70, and HSP 90) in Medulloblastoma 
    Hauser, Péter; Hanzély Z; Jakab, Zsuzsanna; Oláh L; Malét-Szabó, Erika; Jeney, András; Schuler, Dezső; Fekete, György; Bognár, László; Garami, Miklós (2006)
    Expression of heat shock proteins (HSPs) is of prognostic significance in several tumor types. HSP expression levels were determined in medulloblastomas and tested whether HSPs expression was associated with prognostic ...